Table 5.
Secondary outcomes in patients <21 years of age.
| <21 and received capsaicin (n = 17) | <21 and did not receive capsaicin (n = 8) | p | OR | 95% CI | |
|---|---|---|---|---|---|
| Secondary outcomes | |||||
|
| |||||
| Total ED length of stay (median) – hours | 6 | 4.53 | 0.918 | ||
| Total medications for symptom relief received – median, No. (range) | 3 | 2 | 0.685 | ||
| Admitted due to uncontrolled CHS symptoms – No. (%) | 3 (17.6) | 1 (12.5) | 0.745 | 1.50 | (0.131–17.180) |
| Return to ED in 24 h for same symptoms or complaint – No. (%) | 0 | 0 | 0.724 | 0.49 | (0.009–26.645) |
| Time to discharge or admission after administration of capsaicin or first agent (average) – hours | 3.12 | 4.92 | 0.333 | ||
| Change in pain score after administration of capsaicin or first agent – average (14 complete records) | −0.22 | −2.4 | 0.199 | ||